275 related articles for article (PubMed ID: 6434739)
1. Occult lead intoxication in patients with gout and kidney disease.
Wright LF; Saylor RP; Cecere FA
J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
[TBL] [Abstract][Full Text] [Related]
2. Occult lead intoxication as a cause of hypertension and renal failure.
Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
[TBL] [Abstract][Full Text] [Related]
3. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
Orfanos CE; Künzig M
Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
[TBL] [Abstract][Full Text] [Related]
4. Elevated lead burden in Chinese patients without occupational lead exposure.
Lin JL; Lim PS
Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500
[TBL] [Abstract][Full Text] [Related]
5. The role of lead in gout nephropathy.
Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP
N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160
[No Abstract] [Full Text] [Related]
6. Lead and the kidney: nephropathy, hypertension, and gout.
Perazella MA
Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
[TBL] [Abstract][Full Text] [Related]
7. Urinary lead excretion in uremic patients.
Behringer D; Craswell P; Mohl C; Stoeppler M; Ritz E
Nephron; 1986; 42(4):323-9. PubMed ID: 3083277
[TBL] [Abstract][Full Text] [Related]
8. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy.
Wedeen RP
Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486
[TBL] [Abstract][Full Text] [Related]
9. ["Terzo fuoco", lead poisoning and chronic renal failure].
Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
[TBL] [Abstract][Full Text] [Related]
10. Body lead stores and urate excretion in men with chronic renal disease.
Lin JL; Huang PT
J Rheumatol; 1994 Apr; 21(4):705-9. PubMed ID: 8035397
[TBL] [Abstract][Full Text] [Related]
11. [Renal insufficiency and uric gout in a lead worker (clinicopathologic conference)].
Ruiz M; Furió Bacete V; Juárez Centeno D
Rev Clin Esp; 1985 Nov; 177(7):343-52. PubMed ID: 4081216
[No Abstract] [Full Text] [Related]
12. Contribution of lead to hypertension with renal impairment.
Batuman V; Landy E; Maesaka JK; Wedeen RP
N Engl J Med; 1983 Jul; 309(1):17-21. PubMed ID: 6406892
[TBL] [Abstract][Full Text] [Related]
13. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
14. Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study.
Shadick NA; Kim R; Weiss S; Liang MH; Sparrow D; Hu H
J Rheumatol; 2000 Jul; 27(7):1708-12. PubMed ID: 10914856
[TBL] [Abstract][Full Text] [Related]
15. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
Colleoni N; D'Amico G
Nephron; 1986; 44(1):32-5. PubMed ID: 3092121
[TBL] [Abstract][Full Text] [Related]
16. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?
Lin JL; Lim PS
J Hum Hypertens; 1994 Jul; 8(7):495-500. PubMed ID: 7932512
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of renal urate excretion].
Häntzschel U; Költzsch V
Z Gesamte Inn Med; 1978 Mar; 33(6):180-4. PubMed ID: 645153
[TBL] [Abstract][Full Text] [Related]
18. Chronic lead poisoning: a "forgotten" cause of renal disease.
Benjelloun M; Tarrass F; Hachim K; Medkouri G; Benghanem MG; Ramdani B
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):83-6. PubMed ID: 17237897
[TBL] [Abstract][Full Text] [Related]
19. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout.
Moriwaki Y; Yamamoto T; Takahashi S; Yamakita J; Tsutsumi Z; Hada T
J Rheumatol; 2001 Jun; 28(6):1306-10. PubMed ID: 11409124
[TBL] [Abstract][Full Text] [Related]
20. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
